ESC 365 - New insights into glucagon-like peptide-1 receptor agonist treatment considerations.

Open Access

New insights into glucagon-like peptide-1 receptor agonist treatment considerations.

Session: Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice

Topic: Diabetes and the Heart

Speaker: Professor S. Verma (Toronto, CA)

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

31 presentations

3 followers

3 more presentations in this session

Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice.

Speaker: Doctor B. Scirica (Boston, US)

Clinical aspects: type 2 diabetes, cardiovascular disease and glucagon-like peptide-1 receptor agonists.

Speaker: Professor M. Pfeffer (Boston, US)

Perspective on glucagon-like peptide-1 receptor agonists in type 2 diabetes and cardiovascular disease: Interactive discussion.

Speaker: Doctor B. Scirica (Boston, US) Professor S. Verma (Toronto, CA) Professor M. Pfeffer (Boston, US)

Access the full session

Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice

Speakers: Professor S. Verma, Doctor B. Scirica, Professor M. Pfeffer, Doctor B. Scirica, Professor S. Verma...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources